Axogen Statistics
Total Valuation
Axogen has a market cap or net worth of $2.96 billion. The enterprise value is $2.63 billion.
| Market Cap | 2.96B |
| Enterprise Value | 2.63B |
Important Dates
The last earnings date was Wednesday, October 28, 2026, before market open.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Axogen has 59.73 million shares outstanding. The number of shares has increased by 12.44% in one year.
| Current Share Class | 59.73M |
| Shares Outstanding | 59.73M |
| Shares Change (YoY) | +12.44% |
| Shares Change (QoQ) | +15.35% |
| Owned by Insiders (%) | 1.91% |
| Owned by Institutions (%) | 90.40% |
| Float | 54.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.08 |
| Forward PS | 8.39 |
| PB Ratio | 5.96 |
| P/TBV Ratio | 6.06 |
| P/FCF Ratio | 134.16 |
| P/OCF Ratio | 104.25 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 119.25 |
Financial Position
The company has a current ratio of 12.02, with a Debt / Equity ratio of 0.04.
| Current Ratio | 12.02 |
| Quick Ratio | 10.48 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.88 |
| Interest Coverage | -5.72 |
Financial Efficiency
Return on equity (ROE) is -10.35% and return on invested capital (ROIC) is -2.44%.
| Return on Equity (ROE) | -10.35% |
| Return on Assets (ROA) | -2.25% |
| Return on Invested Capital (ROIC) | -2.44% |
| Return on Capital Employed (ROCE) | -2.69% |
| Weighted Average Cost of Capital (WACC) | 10.66% |
| Revenue Per Employee | $429,141 |
| Profits Per Employee | -$51,322 |
| Employee Count | 622 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 1.54 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +122.77% in the last 52 weeks. The beta is 1.17, so Axogen's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +122.77% |
| 50-Day Moving Average | 42.85 |
| 200-Day Moving Average | 39.76 |
| Relative Strength Index (RSI) | 73.11 |
| Average Volume (20 Days) | 1,823,533 |
Short Selling Information
The latest short interest is 5.12 million, so 8.58% of the outstanding shares have been sold short.
| Short Interest | 5.12M |
| Short Previous Month | 4.70M |
| Short % of Shares Out | 8.58% |
| Short % of Float | 9.38% |
| Short Ratio (days to cover) | 3.57 |
Income Statement
In the last 12 months, Axogen had revenue of $266.93 million and -$31.92 million in losses. Loss per share was -$0.62.
| Revenue | 266.93M |
| Gross Profit | 198.00M |
| Operating Income | -13.81M |
| Pretax Income | -31.92M |
| Net Income | -31.92M |
| EBITDA | -6.96M |
| EBIT | -13.81M |
| Loss Per Share | -$0.62 |
Balance Sheet
The company has $348.07 million in cash and $19.47 million in debt, with a net cash position of $328.60 million or $5.50 per share.
| Cash & Cash Equivalents | 348.07M |
| Total Debt | 19.47M |
| Net Cash | 328.60M |
| Net Cash Per Share | $5.50 |
| Equity (Book Value) | 496.10M |
| Book Value Per Share | 8.31 |
| Working Capital | 401.64M |
Cash Flow
In the last 12 months, operating cash flow was $28.36 million and capital expenditures -$6.32 million, giving a free cash flow of $22.04 million.
| Operating Cash Flow | 28.36M |
| Capital Expenditures | -6.32M |
| Depreciation & Amortization | 6.84M |
| Net Borrowing | -48.62M |
| Free Cash Flow | 22.04M |
| FCF Per Share | $0.37 |
Margins
Gross margin is 74.18%, with operating and profit margins of -5.17% and -11.96%.
| Gross Margin | 74.18% |
| Operating Margin | -5.17% |
| Pretax Margin | -11.96% |
| Profit Margin | -11.96% |
| EBITDA Margin | -2.61% |
| EBIT Margin | -5.17% |
| FCF Margin | 8.26% |
Dividends & Yields
Axogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -12.44% |
| Shareholder Yield | -12.44% |
| Earnings Yield | -1.25% |
| FCF Yield | 0.75% |
Analyst Forecast
The average price target for Axogen is $59.09, which is 19.37% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $59.09 |
| Price Target Difference | 19.37% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 25.83% |
| EPS Growth Forecast (3Y) | 50.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Axogen has an Altman Z-Score of 20.77 and a Piotroski F-Score of 3.
| Altman Z-Score | 20.77 |
| Piotroski F-Score | 3 |